1kD — Execution
Funds United Kingdom infant brain development research programs focused on translational collaboration.
The 1kD program is a $45 million Wellcome Leap initiative focused on the first thousand days of infant life — roughly ages 0 to 3 — a developmental window with outsized long-term consequences for brain health. Program Director Dr. Holly Baines leads a multi-team effort to develop integrated models and measurement tools for brain network development in infants, with a specific performance target: c…
Brain network development measurement and scalable interventions targeting executive function improvement in infants during the first thousand days of life (ages 0–3).
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grant Proposal Abstract and Executive Summary: Examples That Work
Learn how to write a grant proposal abstract or executive summary, what to include, how it differs from a project summary, and how to use examples without copying.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
More from Wellcome Leap
All grants from this funder →CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
HOPE — Execution
Wellcome Leap · United States
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
Similar grants
Browse the directory →
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
CHEERS Open Period 1 - All Technical Areas
🇺🇸AFRL · United States
Funds white papers under a standard Broad Agency Announcement inside the Air Force's CHEERS human-performance research strategy.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Continuing Human Enabling Enhancing Restoring and Sustaining
🇺🇸AFRL · United States
Funds Air Force human-performance research, but only through the two grant-eligible solicitations sitting beneath this umbrella notice.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.